AnaptysBio Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,674	1,358	403	570	884	961
Market Cap Growth	167.82%	236.68%	-29.18%	-35.53%	-8.03%	63.35%
Enterprise Value	1,664	1,061	34.13	196.62	461.83	433.59
Last Close Price	57.51	48.48	13.24	21.42	30.99	34.75
Forward PE	32.29	-	-	-	-	16.86
PS Ratio	7.20	5.79	4.42	33.21	85.90	15.21
PB Ratio	130.98	1.68	5.69	6.47	3.37	2.70
P/TBV Ratio	2.02	1.72	5.30	6.55	3.33	2.67
P/FCF Ratio	379.59	69.27	-	-	-	-
P/OCF Ratio	373.74	68.96	-	-	-	-
EV/Sales Ratio	7.16	4.52	0.37	11.46	44.89	6.86
EV/EBITDA Ratio	40.26	21.89	-	-	-	-
EV/EBIT Ratio	40.80	22.15	-	-	-	-
EV/FCF Ratio	377.52	54.10	-	-	-	-
Debt / Equity Ratio	0.01	0.01	0.20	0.18	0.07	0.05
Debt / EBITDA Ratio	0.33	0.29	-	-	-	-
Debt / FCF Ratio	3.09	0.72	-	-	-	-
Net Debt / Equity Ratio	-0.33	-0.37	-5.21	-4.24	-1.61	-1.48
Net Debt / EBITDA Ratio	-6.60	-6.14	3.23	2.28	3.68	9.38
Net Debt / FCF Ratio	-61.88	-15.17	2.72	3.07	5.70	11.15
Asset Turnover	0.67	0.55	0.19	0.03	0.02	0.12
Quick Ratio	7.49	8.94	9.38	10.62	16.99	34.10
Current Ratio	7.58	9.07	9.51	10.87	17.16	34.40
Return on Equity (ROE)	-3.25%	-3.01%	-182.71%	-93.44%	-41.62%	-15.35%
Return on Assets (ROA)	11.69%	11.15%	-24.56%	-30.94%	-18.37%	-10.72%
Return on Invested Capital (ROIC)	254.09%	132.88%	-224.75%	-155.00%	-90.12%	-102.34%
Return on Capital Employed (ROCE)	13.29%	12.54%	-26.94%	-32.91%	-19.01%	-11.10%
FCF Yield	0.26%	1.44%	-	-	-	-
Buyback Yield / Dilution	3.66%	-1.32%	-5.42%	4.41%	-2.68%	-0.47%
Total Shareholder Return	3.66%	-1.32%	-5.42%	4.41%	-2.68%	-0.47%

SEC Filings: 10-K · 10-Q